Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 7/20 | 0.67 |
| ▸ | ACE | P12821 | 6/20 | 0.67 |
| ▸ | CPA1 | P15085 | 4/20 | 0.67 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.67 |
| ▸ | FCER2 | P06734 | 3/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.51 |
| ▸ | CTSC | P53634 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31264142 | 0.97 | MME (0.66) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL29494074 | 0.97 | MME (0.66) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL30519188 | 0.94 | OPRD1 (0.65) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL29576006 | 0.93 | MME (0.61) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL29575342 | 0.93 | MME (0.61) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL31215105 | 0.92 | MME (0.57) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL31215087 | 0.92 | MME (0.57) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL31215093 | 0.91 | MME (0.56) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL31215126 | 0.91 | MME (0.56) | MMEACECPA1ACE2FCER2 | |
| SCHEMBL31129127 | 0.90 | MME (0.55) | MMEACECPA1ACE2FCER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114920804-B | Cetrorelix synthesis process capable of being directly used for pilot scale amplification | 厦门胜泽泰医药科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-115141257-A | Purification method of degarelix | 浙江苏泊尔制药有限公司 | 2022-10-04 | — | — | CN | disclosed |